by xplorelab | Jun 15, 2017 | Funding, Ottawa Hospital Research Institute, Research
Xplore Lab has been awarded $299,000 from the Heart and Stroke Foundation of Canada to study the effectiveness of endothelial colony forming cells (ECFCs) from umbilical cord blood to treat pulmonary hypertension in newborns. The team will test whether these cells can...
by xplorelab | Jun 1, 2017 | Funding, Media, Ottawa Hospital Research Institute, Research, The Ottawa Hospital
Dr. Bernard Thébaud and colleagues have been awarded $550,000 from the Ontario Institute for Regenerative Medicine (OIRM) to further their research in order to prepare for a clinical trial of umbilical cord stem cell therapy for premature babies with BPD, the most...
by xplorelab | Aug 6, 2015 | Awards, Funding, Media, Research
Dr. Thébaud and his research were recently featured in the Ottawa Citizen. The article focused on Dr. Thébaud’s research findings that show damaged lungs of premature infants could benefit from therapy using regenerative medicine. Read the article here, or download a...
by xplorelab | Jul 17, 2015 | Awards, Funding, Research
Dr. Thébaud and his team have been awarded a prestigious 7-year Foundation Scheme grant from the Canadian Institutes of Health Research (CIHR) valued at $3.2 million to support the development of three different kinds of stem cell treatments for babies with...
by xplorelab | Dec 1, 2014 | Awards, Funding, Research
The Lung Association, through the Breathing as One Campaign for Lung Research, recently awarded Dr. Thébaud funding to support his team’s research into correcting surfactant protein genetic mutations that cause fatal respiratory distress in newborn infants. For more...
by xplorelab | Jun 23, 2014 | Awards, Funding, Research
Xplore lab has received a Clinical Translation Impact Grant in the amount of $99,000 from the Canadian Stem Cell Network to continue their work on pre-clinical optimization of umbilical cord-derived perivascular cells for neonatal lung injury. This study will allow us...
